eQcell Inc

eQcellTM Inc. is Canadas premier clinical-stage regenerative medicine company. Founded by Dr. Thomas Koch, Assistant Professor at Canadas University of Guelph, his work reflects 15 years of stem cell research and some $6 million of research investment. The companys target is regenerative therapies for human health utilizing the pathway of conditions and diseases affecting sporting and companion animals globally for which current treatments are ineffective, not fully effective, or palliative. eQcell has developed allogeneic equine cord blood stem cells, for which Dr. Koch published the worlds first paper, and is producing canine adipose-derived mesenchymal stromal cells to provide novel therapeutic...

Stem cells,mesenchymal ,mesenchymal stromal cells,veterinary,biotechnology,cell expansion,preclinical investigation,clinical trials,regenerative medicine,stem cell science,and pharmaceutical products

Eqcell inc operates in the Biotechnology research industry.

Eqcell inc's revenue is 11m - 100m

Eqcell inc has 11 - 50 employees.